Posts

Psychedelic Business Spotlight: October 22

Psychedelic Business Spotlight: October 22

,
This week in psychedelic business news: UK fast tracks DMT for major depressive disorder; Field Trip Health expands its clinical presence in the US; and another psychedelic pharmaceuticals company...
Psychedelic Business Spotlight: July 23, 2021

Psychedelic Business Spotlight: July 23, 2021

,
This week in psychedelic business news: Psychedelics as a treatment for obesity and TBIs, plus another psychedelic company inches toward listing on NYSE American stock exchange.
'PSY' Becomes First U.S.-Listed Psychedelic ETF

Third Psychedelic Stock ETF Coming Soon, Core One Labs Prepares to List on NASDAQ

Advisorshares Plant Medicine ETF will be listed on the NYSE Arca under the symbol PSIL.
Kevin O'Leary-Backed MindMed Is 2nd Psychedelic Company to List On Nasdaq

Kevin O’Leary-Backed MindMed Will Be 2nd Psychedelic Company to List On Nasdaq

MindMed will take its Kevin O'Leary-backed platform onto the Nasdaq Tuesday as only the 2nd psychedelic company to do so.
Psychedelic Start-Up Atai Life Sciences to Raise $100 Million in IPO, 2nd to List on Nasdaq

Psychedelic Start-Up Atai Life Sciences to Raise $100 Million in IPO, 2nd to List on Nasdaq

Atai Life Sciences is now the second psychedelic company to list on Nasdaq, with plans to raise $100 million for its IPO.